BRCA1 and ovarian neoplasm: Based on the above results, we propose a strategy for the use of ovarian tumour histology in the assessment of germline BRCA1 and BRCA2 VUS interpretation under the strict rules of the ACMG/AMP system, based on patient characteristics and available information (Table 3).